Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor‐Stroma Co‐Culture Model
Advanced Healthcare Materials · 2025-11 · 14 (28)
DOI: 10.1002/adhm.202405292 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 31.07.2025. Verfasst von Laura M Bouret und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Polytechnique Montreal, Montreal, Québec, H3T 1J4, Canada. Hauptthemen laut MEDLINE: Plasma Gases, Bioprinting, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: New Frontiers in Research Fund, Natural Sciences and Engineering Research Council of Canada, Apogee Canada First Research Excellence Fund.
Abstract (Originalsprache)
Spine metastases are the most common bone site for breast cancer, with evolving surgery and multidisciplinary care improving outcomes. Current treatments, including chemotherapy and invasive surgery, may damage healthy tissue and leave residual tumors that lead to recurrence. Cold atmospheric plasma (CAP) offers a non‐invasive alternative by delivering reactive oxygen and nitrogen species (RONS) locally to tumor sites, selectively targeting cancer cells while sparing healthy tissue. To assess the impact and selectivity toward tumor cells adjacent to bone‐like tissue, a 3D bioprinted tumor‐stroma model is established using a 1% alginate and 7% gelatin cell‐laden hydrogel to mimic a bone‐like microenvironment. The model co‐cultures triple‐negative MDA‐MB‐231 human breast cancer cells with primary human bone marrow mesenchymal stromal cells to simulate tumor‐stroma interactions. The effects of CAP treatments are assessed through metabolic activity and viability assays over three days. Results demonstrate significant selectivity for cancer cells in both 2D and 3D cultures. CAP minimizes damage to healthy cells, offering the potential for localized treatment over systemic chemotherapies such as doxorubicin. Scavenger experiments further confirm that CAP‐induced cytotoxicity is mediated by oxidative stress, involving both extracellular and intracellular RONS. This novel bioprinted platform highlights CAP as a personalized, non‐invasive treatment for bone metastases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Polytechnique Montreal, Montreal, Québec, H3T 1J4, Canada.
- Department of Engineering Physics, Polytechnique Montreal, Montreal, Québec, H3T 1J4, Canada.
- Department of Surgery, Division of Orthopaedic Surgery, McGill University, Montreal, Québec, H3G 1A4, Canada.
- Surgical & Interventional Sciences Program, Research Institute of the McGill University Health Centre, Montreal, Québec, H3G 1A4, Canada.
ORCID-Profile: Laura M Bouret, Stephan Reuter
Förderung
- New Frontiers in Research Fund
- Natural Sciences and Engineering Research Council of Canada
- Apogee Canada First Research Excellence Fund
- Natural Sciences and Engineering Research Council of Canada - OPSIDIAN program (Optimizing Power Skills in Interdisciplinary, Diverse & Innovative Academic Net…
- Fonds de recherche du Québec - Nature et technologies - Relève Professorale
Zitieren
APA
Bouret, L. M., Billeau, J. B., Weber, M. H., Rosenzweig, D. H., & Reuter, S. (2025). Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor‐Stroma Co‐Culture Model. Advanced Healthcare Materials, 14(28). https://doi.org/10.1002/adhm.202405292
Vancouver
Bouret LM, Billeau JB, Weber MH, Rosenzweig DH, Reuter S. Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor‐Stroma Co‐Culture Model. Advanced Healthcare Materials. 2025;14(28). doi:10.1002/adhm.202405292
BibTeX
@article{Bouret2025,
author = {Bouret, Laura M and Billeau, Jean-Baptiste and Weber, Michael H and Rosenzweig, Derek H and Reuter, Stephan},
title = {Cold Atmospheric Plasma Selectively Disrupts Breast Cancer Growth in a Bioprinted 3D Tumor‐Stroma Co‐Culture Model},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {28},
doi = {10.1002/adhm.202405292}
}
EUVIMED